Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 207 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| ATP8B4 | ENSG00000104043 | 0.00 | 0.00 | 0 | 0 |
| TRPM4 | ENSG00000130529 | 0.00 | 0.49 | 0 | 2 |
| SLC12A7 | ENSG00000113504 | 2.39 | 0.13 | 9 | 1 |
| AIFM1 | ENSG00000156709 | 0.00 | 0.00 | 0 | 0 |
| ADGRF1 | ENSG00000153292 | 0.00 | 0.00 | 0 | 0 |
| KDM5B | ENSG00000117139 | 0.00 | 0.00 | 0 | 0 |
| MMP24 | ENSG00000125966 | 0.00 | 0.00 | 0 | 0 |
| PDE2A | ENSG00000186642 | 0.00 | 0.00 | 0 | 0 |
| SIAE | ENSG00000110013 | 0.00 | 0.82 | 0 | 4 |
| SLC22A3 | ENSG00000146477 | 0.00 | 0.34 | 0 | 2 |
| GAD1 | ENSG00000128683 | 0.00 | 0.00 | 0 | 0 |
| ALDH3A1 | ENSG00000108602 | 0.69 | 0.00 | 1 | 0 |
| CYP4F11 | ENSG00000171903 | 0.00 | 0.00 | 0 | 0 |
| MMP9 | ENSG00000100985 | 0.00 | 0.00 | 0 | 0 |
| SMO | ENSG00000128602 | 0.11 | 0.14 | 1 | 1 |
| CYP2E1 | ENSG00000130649 | 0.00 | 0.37 | 0 | 3 |
| SLC52A2 | ENSG00000185803 | 0.88 | 0.00 | 3 | 0 |
| SLC2A5 | ENSG00000142583 | 0.00 | 1.50 | 0 | 3 |
| CHI3L2 | ENSG00000064886 | 0.00 | 0.10 | 0 | 1 |
| MASP2 | ENSG00000009724 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 207 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.